MAXHEALTH.NSMAXHEALTH.NSNSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +39.95% | +34.21% | +31.41% | +25.07% | +10.66% |
| Gross Profit Growth | +40.01% | +33.80% | +31.50% | +55.46% | -37.41% |
| EBITDA Growth | +21.01% | +34.25% | +35.93% | +39.52% | +18.14% |
| Operating Income Growth | +40.07% | +31.15% | +32.20% | -35.12% | -45.65% |
| Net Income Growth | -17.47% | +26.82% | +30.35% | +74.34% | +26.01% |
| EPS Growth | -17.45% | +26.64% | +30.45% | +74.14% | +25.61% |
| EPS Diluted Growth | -17.85% | +26.36% | +30.17% | +74.31% | +26.64% |
| Weighted Average Shares Growth | -0.11% | +0.69% | -0.04% | +0.11% | +0.21% |
| Weighted Average Shares Diluted Growth | +0.46% | +0.44% | +0.14% | +0.02% | -0.49% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +38.39% | +0.00% | +77.42% | +0.00% |
| Inventory Growth | +0.00% | +33.03% | +0.00% | +22.45% | +0.00% |
| Asset Growth | +0.00% | +26.79% | +0.00% | +24.03% | +0.00% |
| Book Value per Share Growth | +12.27% | +10.80% | +11.61% | +14.11% | +0.00% |
| Debt Growth | +0.00% | +131.75% | +0.00% | +85.22% | +0.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +39.88% | +38.90% | +30.18% | +27.64% | -20.66% |